These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Mechanisms of immunity in cancer. Baldwin RW Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216 [No Abstract] [Full Text] [Related]
25. Regulatory T cells, tumour immunity and immunotherapy. Zou W Nat Rev Immunol; 2006 Apr; 6(4):295-307. PubMed ID: 16557261 [TBL] [Abstract][Full Text] [Related]
26. [Radiation therapy and host immunity in malignant tumors (author's transl)]. Makidono A; Makidono R Rinsho Hoshasen; 1978 Aug; 23(8):849-57. PubMed ID: 357791 [No Abstract] [Full Text] [Related]
27. [Molecular mechanisms of tumor and immune system interaction]. Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839 [No Abstract] [Full Text] [Related]
28. Functional ontogeny of human lymphoid cells as a factor in maternal-fetal tolerance. Siegal FP Prog Clin Biol Res; 1981; 70():41-6. PubMed ID: 6458825 [No Abstract] [Full Text] [Related]
29. [Subpopulations of human T-lymphocytes and their suppressor functions]. Brondz BD Ter Arkh; 1980; 52(9):120-32. PubMed ID: 6449090 [No Abstract] [Full Text] [Related]
30. Antigen-specific suppressor ("blocking") factors in tumor immunity. Hellström KE; Hellström I; Nelson K Biomembranes; 1983; 11():365-88. PubMed ID: 6219721 [No Abstract] [Full Text] [Related]
31. Regulation of immune functions in the fetus and newborn. Murgita RA; Wigzell H Prog Allergy; 1981; 29():54-133. PubMed ID: 6460251 [No Abstract] [Full Text] [Related]
32. Escape mechanisms in tumor immunity: an update. Müller L; Kiessling R; Rees RC; Pawelec G J Environ Pathol Toxicol Oncol; 2002; 21(4):277-330. PubMed ID: 12510961 [TBL] [Abstract][Full Text] [Related]
33. Suppressor cell function in solid tumor cancer patients. Von Roenn J; Harris JE; Braun DP J Clin Oncol; 1987 Jan; 5(1):150-9. PubMed ID: 2949064 [No Abstract] [Full Text] [Related]
34. [Metastasis. Natural history and therapeutic data]. Scolozzi R; Boccafogli A; Furlani RF; Vicentini L Recenti Prog Med; 1982 Apr; 72(4):446-81. PubMed ID: 6216563 [No Abstract] [Full Text] [Related]
35. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms. Lizée G; Radvanyi LG; Overwijk WW; Hwu P Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564 [TBL] [Abstract][Full Text] [Related]
36. Immune response to tumor cells in domestic animals. Trainin Z; Essex M J Am Vet Med Assoc; 1982 Nov; 181(10):1125-33. PubMed ID: 6294028 [No Abstract] [Full Text] [Related]
37. Abnormalities of immunoregulatory cells in immunodeficiency disease and cancer. Broder S; Muul L; Megson M; Waldmann TA Prog Clin Biol Res; 1981; 58():93-120. PubMed ID: 6455670 [No Abstract] [Full Text] [Related]
39. [Cooperation of B- and T-lymphocytes of the human in vitro and in vivo]. Ambrosius H; Schäffner H Z Gesamte Inn Med; 1980 Jan; 35(2):38-42. PubMed ID: 6447413 [TBL] [Abstract][Full Text] [Related]
40. Analyses and perspectives in cancer immunotherapy. Nguyen van Binh P; Duc HT Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]